Takeda and Protagonist Therapeutics have submitted a new drug application to the FDA for rusfertide for adults with ...

BioMendics advances its TAMES-02 trial of TolaSure™, a potential disease-modifying topical therapy for Epidermolysis Bullosa ...

Data from a comparative study found liraglutide and dulaglutide presented similar effectiveness as semaglutide in the ...

When I tell people I work in suicide prevention, they often assume I spend my days answering crisis calls or serving as a ...

Large language models could transform digestive disorder management, but further RCTs are essential to validate their ...

Auricular vagal neuromodulation therapy is a non-invasive and non-surgical treatment that could aid cardiovascular disease ...

The engagement establishes a multi-phase framework to support AI enabled capital efficient development of Teverelix, a next generation GnRH antagonist, as a first in class market product for acute ...

SynuSight Biotech has licensed 18F-FD4 to XingImaging and to ABLi Therapeutics to evaluate alpha-synuclein clearance from the brain in response to risvodetinib treatment ...

Dr. Raza Bokhari, Executive Chairman & CEO of Medicus will deliver a company presentation as Medicus enters 2026 with multiple Phase 2 Catalysts across clinical, regulatory, and pipeline expansion ...

Zenas BioPharma, Inc. (“Zenas,” “Zenas BioPharma” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and ...

Contaminated drinking water in Indore, India, was linked to 10 deaths and more than 270 hospitalizations, according to ...